Panacea Life Sciences Holdings, Inc. Liquidation Value

Cash & Equivalents

$107,643
As of 2024-03-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $107,643
Total Obligations: -$27.26M
$-27.15M
Per share: $-1.48
Period: 2024-03-31
incomplete 1 component missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $107,643
AR: $270,851
Total Obligations: -$27.26M
$-26.88M
Per share: $-1.47
Period: 2024-03-31
incomplete 1 component missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $107,643
AR: $270,851
Inventory: $4.06M
Total Obligations: -$27.26M
$-22.81M
Per share: $-1.25
Period: 2024-03-31
incomplete 1 component missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-27.15M$-1.48
Liquid Liquidation Value$-26.88M$-1.47
Operating Liquidation Value$-22.81M$-1.25

Key Components (as of 2024-03-31)

Data as of 2024-03-31 from 10-Q filed 2024-05-06. View on SEC EDGAR →

Cash & Equivalents$107,643
Accounts Receivable$270,851
Inventory$4.06M
Current Liabilities$20.39M
Long-term Debt (?)N/A
Op. Lease Liability (?)$3.07M
Finance Lease (?)N/A
Shares Outstanding18.3M

Explore all 94 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2024-03-31$107,643$270,851$4.06MN/A$20.39MN/A$3.07MN/A
2023-12-31$100,922$263,970$4.01MN/A$19.45MN/A$3.25MN/A

Comments

SEC Filings

PeriodFormFiledLink
2024-03-31 10-Q 2024-05-06 View
2023-12-31 10-K 2024-04-01 View
2023-09-30 10-Q 2023-11-14 View
2023-06-30 10-Q 2023-08-15 View
2023-03-31 10-Q 2023-05-12 View
2022-12-31 10-K 2023-03-30 View
2022-09-30 10-Q 2022-11-14 View
2022-06-30 10-Q 2022-08-15 View

AI Insights

AI Insight·Generated 2026-05-06

PLSH carries a deeply negative liquidation posture as of March 31, 2024. MFFAIS reports a cash liquidation value of negative $23.4 million, consistent with the balance-sheet arithmetic: total assets of $17.4 million face total liabilities of $27.0 million at face value, producing book equity of negative $9.6 million before any liquidation haircuts are applied. Once haircuts are applied, the deficit widens materially. The largest asset classes under liquidation scrutiny are PP&E net ($6.1 million; 50-70% recovery = ~$3.0-4.3 million), inventory ($4.1 million; 60% = ~$2.4 million), operating ROU asset ($3.7 million; zero recovery as it extinguishes with the lease obligation but the lease liability of $3.8 million remains at face value), intangibles/goodwill ($3.0 million tagged as both IntangibleAssetsNetExcludingGoodwill and Goodwill; zero recovery), and cash ($0.1 million at par). Total liquidation asset recovery is roughly $6.0-7.5 million against $27.0 million of face-value liabilities, implying an equity recovery deficit in the range of negative $19 to negative $21 million—directionally consistent with the MFFAIS operating liquidation value of negative $19.0 million. The liability stack is dominated by CEO/related-party notes payable of $11.8 million (J&N Note $4.1 million at 12%; CEO Line of Credit $7.7 million at 10%), operating lease obligations to the same related party ($3.8 million present value), other related-party long-term liabilities of $3.6 million (Fixed Asset Loan and J&N Building Loan with no maturity date), accrued current liabilities of $5.2 million (including $2.3 million unpaid lease balances and $3.3 million accrued related-party interest), and a $99k SBA EIDL. QoQ change from December 31, 2023 to March 31, 2024: the CEO note grew by ~$375k (interest accrual), accrued interest on related-party loans rose by ~$420k in aggregate, and total short-term operating lease obligations increased from $2.9 million to $3.0 million due to unpaid balance accumulation. The filing carries an explicit going-concern qualification. Cash was $108k at period end; primary financing is CEO drawdowns. The prior filing provided is the 10-K for December 31, 2023; the 10-Q represents one quarter of additional deterioration. Filing discusses accrued CEO salary obligations in MD&A narrative but does not separately tag that liability in XBRL—the compensation accrual is subsumed within AccountsPayableAndAccruedLiabilitiesCurrent.

Flags

Loading flags...

AI Insight Discussion

Loading...

Community Notes

Loading notes...

Questions

Loading questions...